Business / Finance

RSS

Can-Fite BioPharma executes confidentiality agreements for commercialization of CF101 drug

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it executed confidentiality agreements with 10 established pharmaceutical and biotechnology companies with respect to potential negotiations for the commercialization of CF101 for the treatment of autoimmune inflammatory indications.

4 Nov 2013

JDRF partners with Pfizer's CTI to support diabetes research

JDRF, the leading global organization funding type 1 diabetes research, announced today a partnership with Pfizer's Centers for Therapeutic Innovation to support the development and translation of promising diabetes research.

4 Nov 2013

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

Covalon Technologies Ltd., an advanced medical technologies company, today announced that it has licensed its antimicrobial silicone adhesive technology to Molnlycke Heath Care.

4 Nov 2013

NeuroSky forms strategic partnership with SoftBank Mobile to improve health and wellness

NeuroSky, a global leader in body and mind monitoring and analysis technologies, today announced that is has secured a significant investment from SoftBank Corp. to form a strategic partnership with SoftBank Mobile Corp.

4 Nov 2013

RaySearch Laboratories, Hitachi sign long-term distribution agreement

RaySearch Laboratories AB has entered into a long-term distribution agreement with Hitachi Medical Corporation based in Tokyo, Japan. The agreement means that Hitachi will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation® on the Japanese market from April 1, 2014.

4 Nov 2013

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Polyphor Ltd, a privately held pharmaceutical company, and Roche announced today that they have entered into an exclusive worldwide license agreement to develop and commercialize Polyphor's investigational macrocycle antibiotic, POL7080, for patients suffering from bacterial infections caused by Pseudomonas aeruginosa.

4 Nov 2013

Avidus Management Group provides market guidance relating to acquisition strategy

Avidus Management Group Inc. ("Avidus" or the "Company"), today provided market guidance relating to its acquisition strategy.

31 Oct 2013

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

31 Oct 2013

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Cardinal Health today reported fiscal year 2014 first-quarter revenue of $24.5 billion and a 36 percent increase in non-GAAP diluted earnings per share (EPS) from continuing operations to $1.10. Non-GAAP operating earnings increased 13 percent to $532 million.

31 Oct 2013

Cigna posts strong revenue growth in third quarter 2013

Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.

31 Oct 2013

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma Inc. today reported results for the first quarter of its fiscal year ending June 30, 2014.

31 Oct 2013

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Valeant Pharmaceuticals International, Inc. announces third quarter financial results for 2013. "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.

31 Oct 2013

Novaquest closes $459 million private equity fund

NovaQuest Capital Management, L.L.C. is pleased to announce the final closing of NovaQuest Pharma Opportunities Fund III, L.P., a $459 million private equity fund focused on providing structured finance solutions to biopharmaceutical companies ("Fund III").

31 Oct 2013

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2013.

31 Oct 2013

Viropharma announces financial results for third quarter 2013

ViroPharma Incorporated reported today its financial results for the third quarter ended September 30, 2013. Net sales were $113 million for the third quarter ended September 30, 2013, as compared to $91 million in the same three months of 2012.

31 Oct 2013

Lifestyle Lift, Alliance Data sign multi-year agreement

Alliance Data Systems Corporation, a leading provider of loyalty and marketing solutions derived from transaction-rich data, today announced its Retail Services business has signed a multi-year agreement to provide private label credit card services for Lifestyle Lift (www.lifestylelift.com), further extending Alliance Data's presence in the elective medical and cosmetic procedure segment.

31 Oct 2013

MEDNAX reports revenue growth of 17.3% to $555M

MEDNAX, Inc., the national medical group specializing in neonatal, maternal-fetal, pediatric cardiology, other pediatric subspecialties and anesthesia physician services, today reported earnings of $1.52 per share for the three months ended September 30, 2013 resulting from strong revenue growth, primarily from recent acquisitions.

31 Oct 2013

Business / Finance

Can-Fite BioPharma executes confidentiality agreements for commercialization of CF101 drug

JDRF partners with Pfizer's CTI to support diabetes research

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

NeuroSky forms strategic partnership with SoftBank Mobile to improve health and wellness

RaySearch Laboratories, Hitachi sign long-term distribution agreement

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Avidus Management Group provides market guidance relating to acquisition strategy

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Cigna posts strong revenue growth in third quarter 2013

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Novaquest closes $459 million private equity fund

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

Viropharma announces financial results for third quarter 2013

Lifestyle Lift, Alliance Data sign multi-year agreement

MEDNAX reports revenue growth of 17.3% to $555M

Hemp shareholders set to receive additional stock in Bioadaptives

Alkermes reports 38% of year-over-year revenue growth from key products

Nanosonics named healthcare industry’s Company of the Year for 2013

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News